Key Highlights
- ARK Invest acquired 39,691 Tesla shares totaling $14.3M distributed among three ETFs on April 6, 2026
- Tesla stock declined over 2% to $352.82 following disappointing Q1 delivery figures
- ARK divested 25,240 shares of Teradyne valued at $7.8M, extending a week-long reduction strategy
- Wedbush analyst Dan Ives maintained a Buy rating and $600 price target on Tesla
- JPMorgan’s Ryan Brinkman maintained a Sell rating with a $145 price target
Cathie Wood’s ARK Invest executed multiple portfolio adjustments on Monday, April 6, 2026, adding to its Tesla holdings while reducing exposure to semiconductor testing firm Teradyne.
Tesla shares experienced a decline exceeding 2% during the trading session, settling at $352.82. The downturn followed the electric vehicle manufacturer’s underwhelming Q1 delivery figures.
Wood accumulated 39,691 Tesla shares distributed among three ETFs — ARK Innovation, ARK Autonomous Technology & Robotics, and ARK Space Exploration & Innovation. The combined acquisition amounted to approximately $14.3 million.
This purchase represents part of a consistent pattern. ARK has been expanding its Tesla holdings methodically, capitalizing on the recent share price decline as an entry point.
On the divestment side, ARK liquidated 25,240 Teradyne shares valued at $7.8 million from its ARKK and ARKQ funds. This action follows previous sales executed on March 30 and March 31, indicating a systematic reduction strategy.
Analyst Community Remains Divided on Tesla
Wood’s bullish stance contrasts with mixed sentiment across the analyst community regarding Tesla at present.
Wedbush analyst Dan Ives, a five-star-rated analyst, maintained his Buy rating and $600 price target following the delivery disclosure. He characterized the results as underwhelming but noted that subdued demand had already been anticipated by most market observers.
JPMorgan analyst Ryan Brinkman presented a contrasting perspective. He preserved his Sell rating with a price target of $145, asserting Tesla’s performance has “collapsed” across critical metrics.
The substantial spread between these two price targets — $145 versus $600 — illustrates the significant disagreement on Wall Street regarding the stock’s trajectory.
Among 32 analysts monitored over the past three months, Tesla carries a consensus Hold rating. The breakdown includes 13 Buy, 11 Hold, and 8 Sell recommendations.
The average price target stands at $393.97, representing approximately 11.66% potential upside from Monday’s closing price.
Additional ARK Portfolio Adjustments on April 6
ARK additionally divested 29,773 shares of BWX Technologies for $6.4 million and 8,484 shares of Cameco for $955,043.
The investment firm also liquidated 92,758 shares of Strata Critical Medical, generating approximately $384,945. This divestment pattern has persisted since the previous week.
Regarding acquisitions, ARK added 4,394 shares of Kodiak AI through its ARKQ ETF, totaling $32,603. ARK has been building its Kodiak AI position since March 30.
Current Market Position
As of April 6, Tesla shares settled at $352.82, with the consensus analyst price target of $393.97 indicating modest upside potential from present valuation levels.
